Skip to main content
Clinical Trials/NCT07258732
NCT07258732
Active, not recruiting
Not Applicable

Study on the Impact of Probiotics on Postoperative Gastrointestinal Symptoms and Gut Microbiota After Sleeve Gastrectomy: A Randomized-Control Trial

University of Warmia and Mazury in Olsztyn1 site in 1 country200 target enrollmentStarted: July 10, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
University of Warmia and Mazury in Olsztyn
Enrollment
200
Locations
1
Primary Endpoint
Assessment of the impact of probiotics on the resolution of constipation after sleeve gastrectomy

Overview

Brief Summary

The planned study aims to assess whether probiotics improve the quality of life in patients during the early postoperative period following sleeve gastrectomy, and whether they influence the absorption of micro- and macronutrients.

Patients eligible for inclusion will have a BMI of 40 kg/m² or higher and must have successfully completed the qualification process for sleeve gastrectomy. Exclusion criteria include chronic gastrointestinal diseases, antibiotic use within 4 weeks prior to surgery, and lack of consent to participate in the study.

On the day before surgery, a stool sample will be collected from each patient for microbiological analysis to assess the composition of gut bacteria. Patients will then undergo sleeve gastrectomy using a standard surgical technique.

After the operation, participants will be randomized into two groups. The first group will receive probiotics containing Bifidobacterium animalis AMT30, Bifidobacterium breve AMT32, and Lactobacillus plantarum AMT14. These strains are deposited in the Polish Collection of Microorganisms at the Polish Academy of Sciences in Wrocław and are protected by Polish, European, and U.S. patents. The second group will receive a placebo.

As part of follow-up, stool samples will be collected again one month and three months after surgery for comparative microbiological analysis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age over 18 years.
  • BMI over 40 kg/m² or over 35 kg/m² with obesity-related comorbidities.
  • Successful qualification for sleeve gastrectomy.
  • Informed consent to participate in the study.

Exclusion Criteria

  • Age under 18 years.
  • Chronic gastrointestinal diseases.
  • Use of antibiotic therapy within 4 weeks prior to surgery.
  • Lack of consent to participate in the study.

Outcomes

Primary Outcomes

Assessment of the impact of probiotics on the resolution of constipation after sleeve gastrectomy

Time Frame: one and three months after surgery

The primary outcome of the study is to assess the effect of probiotics on the frequency of defecation in the early weeks following surgery. The patient would be asked whether constipation occurred (yes or no).

Secondary Outcomes

  • Metabolic changes after the probiotics use in patients after SG(one and three months after surgery)
  • Assessment of the impact of probiotics on gastrointestinal symptoms after SG(one and three months after surgery)

Investigators

Sponsor
University of Warmia and Mazury in Olsztyn
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Natalia Dowgiałło-Gornowicz, MD, PhD

Associate Professor

University of Warmia and Mazury in Olsztyn

Study Sites (1)

Loading locations...

Similar Trials